Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
topic_facet:"Recruitment Status: Active, not recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (4.478)
1
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy : A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer : A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery : A Phase II and Pilot Trial of PD-1 Blockade With Pembrolizumab (MK-3475) in Patients With Resectable or Unresectable Desmoplastic Melanoma (DM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer : Pilot Trial of Anastrozole and Palbociclib as First-Line Therapy and as Maintenance Therapy After First Line Chemotherapy in Hormone Receptor Positive, HER2-Negative Postmenopausal Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC : A Randomized Trial of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations : A Phase 2 Study of Veliparib (ABT-888) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients With Newly Diagnosed High-Grade Glioma (HGG) Without H3 K27M or BRAFV600 Mutations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases : The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab : Randomized Phase II Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab in Locally Advanced Cervical Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone : A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab : Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab (neoHIP)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[448]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Medienart
4.478
Aufsätze
4.478
E-Artikel
4.478
E-Ressourcen
Zeitschriftentitel
4.160
ClinicalTrials.gov
318
WHO International Clinical Trials Registry Plat...
Thema
4.478
610
Phase: Phase 2
Recruitment Status: Active, not recruiting
4.478
Study Type: Interventional
439
Carcinoma
308
Breast Neoplasms
291
Lymphoma
228
Neoplasms
221
Carcinoma, Non-Small-Cell Lung
206
Leukemia
205
Lung Neoplasms
185
Recurrence
173
Prostatic Neoplasms
165
Multiple Myeloma
161
Adenocarcinoma
129
Carcinoma, Squamous Cell
127
Neoplasms, Plasma Cell
120
Melanoma
113
Colorectal Neoplasms
102
Leukemia, Myeloid
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4.377
2020-
101
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.474
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...